Sonoma Pharmaceuticals, Inc. (SNOA) Corporate Subsidiaries
Sonoma Pharmaceuticals, Inc. (SNOA) is a publicly traded company on the Nasdaq, categorized under SIC 3841 (Surgical & Medical Instruments & Apparatus). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SNOA
CIK: 1367083
Exchange: Nasdaq
SIC 3841: Surgical & Medical Instruments & Apparatus
Fiscal Year End: 03/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Frazier & Deeter, LLC
Auditor SinceSince 3/31/2022 12:00:00 AM
Lead Engagement PartnerPatrick Crouch
Audit LocationNashville, Tennessee, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-A12B/A | 2026-10-06 | — | AMENDMENT TO FORM 8-A12B | 0001683168-26-007659 | View SEC Doc Filr Page |
| 8-K | 2026-10-06 | 2026-10-06 | CURRENT REPORT | 0001683168-26-007657 | View SEC Doc Filr Page |
| 8-K | 2026-09-17 | 2026-09-16 | CURRENT REPORT | 0001683168-26-007199 | View SEC Doc Filr Page |
| 8-K | 2026-08-19 | 2026-08-19 | FORM 8-K | 0001683168-26-006608 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | FORM 10-Q FOR JUN 2026 | 0001683168-26-006024 | View SEC Doc Filr Page |
| DEF 14A | 2026-07-28 | 2026-09-16 | DEFINITIVE PROXY STATEMENT | 0001683168-26-005810 | View SEC Doc Filr Page |
| DEFA14A | 2026-07-23 | — | NOTICE OF ADJOURNMENT | 0001683168-26-005718 | View SEC Doc Filr Page |
| 4 | 2026-07-09 | 2026-07-09 | 4 Filing | 0001683168-26-005423 | View SEC Doc Filr Page |
| 4 | 2026-07-09 | 2026-07-09 | 4 Filing | 0001683168-26-005422 | View SEC Doc Filr Page |
| 4 | 2026-07-09 | 2026-07-09 | 4 Filing | 0001683168-26-005421 | View SEC Doc Filr Page |
| 4 | 2026-07-09 | 2026-07-09 | 4 Filing | 0001683168-26-005420 | View SEC Doc Filr Page |
| 4 | 2026-07-09 | 2026-07-09 | 4 Filing | 0001683168-26-005419 | View SEC Doc Filr Page |
| 4 | 2026-07-09 | 2026-07-09 | 4 Filing | 0001683168-26-005418 | View SEC Doc Filr Page |
| S-8 | 2026-07-09 | — | FORM S-8 | 0001683168-26-005405 | View SEC Doc Filr Page |
| DEFA14A | 2026-06-24 | — | FORM DEFA14A | 0001683168-26-005092 | View SEC Doc Filr Page |
| 8-K | 2026-06-18 | 2026-06-18 | CURRENT REPORT | 0001683168-26-004975 | View SEC Doc Filr Page |
| 424B5 | 2026-06-18 | — | PROSPECTUS SUPPLEMENT | 0001683168-26-004971 | View SEC Doc Filr Page |
| 10-K | 2026-06-16 | 2026-03-31 | FORM 10-K FOR MAR 2026 | 0001683168-26-004871 | View SEC Doc Filr Page |
| DEF 14A | 2026-05-05 | 2026-06-24 | DEFINITIVE PROXY STATEMENT | 0001683168-26-003495 | View SEC Doc Filr Page |
| 8-K | 2026-04-30 | 2026-04-24 | CURRENT REPORT | 0001683168-26-003381 | View SEC Doc Filr Page |
| 424B4 | 2026-04-27 | — | PROSPECTUS | 0001683168-26-003212 | View SEC Doc Filr Page |
| PRE 14A | 2026-04-27 | 2026-04-24 | FORM PRE 14A | 0001683168-26-003211 | View SEC Doc Filr Page |
| EFFECT | 2026-04-23 | — | EFFECT Filing | 9999999995-26-001319 | View SEC Doc Filr Page |
| S-1/A | 2026-04-23 | — | AMENDMENT NO. 1 TO FORM S-1 | 0001683168-26-003139 | View SEC Doc Filr Page |
| CORRESP | 2026-04-22 | — | CORRESP Filing | 0001683168-26-003141 | View SEC Doc Filr Page |